Danazol causes significant changes in the cardiometabolic profile of patients with acquired aplastic anaemia
{{output}}
Background: Danazol is frequently used in treating patients with acquired aplastic anaemia (AA) in resource-constraint settings. We aimed to evaluate the cardiometabolic side effects of Danazol in patients with AA. ... ...
